HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 (DNA qualitative genotyping, swab/M)
We remind you that independent interpretation of the results is unacceptable, the information provided below is for reference purposes only.
HPV (Human Papillomavirus) genotyping in men detects DNA of high-risk oncogenic types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59. These types are associated with the development of anogenital lesions, including condylomas, as well as certain anogenital cancers. HPV is primarily transmitted through sexual contact and may persist without any symptoms.
Indications
- Detection of HPV infection
- Presence of anogenital warts (condylomas)
- Sexual contact with a partner infected with high-risk HPV
- Assessment of risk for HPV-associated diseases
- Follow-up after treatment of HPV infection
- Urogenital disorders or infertility (upon physician recommendation)
Procedure
Sample collection is performed by a physician in an outpatient setting.
Using a sterile urogenital swab, cells are collected from the urethra and/or from the surface of the glans penis and the perianal region (depending on clinical indications). The procedure takes a few minutes and may cause mild, temporary discomfort.
Method of testing
Molecular genetic method - PCR (polymerase chain reaction) for qualitative detection and genotyping of Human Papillomavirus DNA.
It allows identification of high-risk HPV types.
Sources:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215574/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683586/
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158184
IMPORTANT!
It is crucial to remember that the information provided in this section is not intended for self-diagnosis or self-treatment. If you experience any pain or exacerbation of a condition, you must consult a doctor for diagnostic testing and appropriate treatment. Only a qualified healthcare professional can make an accurate diagnosis and determine the appropriate course of treatment. To obtain the most accurate and consistent evaluation of test results, it is recommended to have them performed at the same laboratory. This is because different laboratories may use varying methods and units of measurement for similar tests.
Preparation:
- Do not perform the test during acute urethral infection
- Abstain from sexual intercourse for 48 hours before testing
- Do not use local antiseptics or ointments in the sampling area for 48 hours
- Avoid urination for 2–3 hours before sample collection
- After antibiotic therapy - testing should be performed after completion of treatment (as recommended by a physician)